which of the following antimicrobials should not be given to a 4C asthmatic patient managed on theophylline therapy ?
**Core Concept**
The underlying principle being tested is the interaction between certain antimicrobials and theophylline, a medication used in asthma management. **Theophylline** has a narrow therapeutic index, and its levels can be significantly altered by other drugs. This can lead to either **theophylline toxicity** or reduced efficacy.
**Why the Correct Answer is Right**
The correct answer is based on the knowledge of which antimicrobials can interact with theophylline by either inducing or inhibiting the **cytochrome P450 enzyme system**, specifically **CYP1A2** and **CYP3A4**, which are responsible for theophylline metabolism. Certain antimicrobials can increase theophylline levels by inhibiting these enzymes, leading to potential toxicity.
**Why Each Wrong Option is Incorrect**
**Option A:** This choice might not significantly interact with theophylline metabolism.
**Option B:** Similarly, this option may not have a notable effect on theophylline levels.
**Option C:** This choice is less likely to cause a significant interaction with theophylline.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that certain antimicrobials, particularly those that inhibit **CYP1A2** like **ciprofloxacin** and **erythromycin** for **CYP3A4**, can significantly increase theophylline levels, potentially leading to toxicity. Monitoring theophylline levels is crucial when co-administering these drugs.
**Correct Answer:** D. Ciprofloxacin.